Key result
GSNOR deficiency reduces systolic calcium and upregulates mitochondrial complexes in female hiPSC cardiomyocytes.
Why the study?
Does GSNOR deficiency alter calcium handling and oxidative phosphorylation-related gene expression in female human induced pluripotent stem cell-derived cardiomyocytes?
Does GSNOR deficiency alter calcium handling and oxidative phosphorylation-related gene expression in female human induced pluripotent stem cell-derived cardiomyocytes?
Answers are grounded in this paper and cite their sources.
GSNOR deficiency in female cardiomyocytes reduces systolic calcium and increases oxidative phosphorylation gene expression, which may contribute to impaired stress response following myocardial infarction.
Introduction: Females are cardioprotected from myocardial infarction (MI) compared to males. However, female mice deficient in S-nitrosoglutathione reductase (GSNOR –/– ), a denitrosylase regulating protein S-nitrosylation (S-NO), exhibit impaired cardiac function following MI compared to WT mice. To investigate the impact of GSNOR deficiency on cardiomyocyte (CM) function, we used human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) from female donor. Hypothesis: GSNOR deficiency alters Ca 2+ handling and oxidative phosphorylation-related gene expression in CMs. Methods: Female hiPSCs lacking GSNOR (GSNOR KO ) were generated using CRISPR-Cas9 gene editing. Sanger sequencing and GSNOR activity were performed to confirm successful knockout. The percentage of cardiac troponin-positive (cTnT + ) cells was quantified using flow cytometry. Calcium handling in response to increasing pacing rate was assessed using the Ca 2+ -sensitive probe Fura-2-AM and an IonOptix system. RNA sequencing was performed to compare parental and mutated iPSC-CMs. Results: Sanger sequencing of isolated clones (N=36) showed that several had an adenine (A) insertion, resulting in a frame shift mutation. Clones (N=6) showed an absence of GSNOR expression and activity, whereas the parental line exhibited normal GSNOR activity. More than 90% of control and GSNOR KO female hiPSC-CMs were cTnT + . Female GSNOR KO hiPSC-CMs (n=3) exhibited reduced levels of Ca 2+ compared with their corresponding controls (N=6 and N=3, respectively) which resembled the pattern observed in CMs isolated from female GSNOR –/– mice (N=3). Particularly, female GSNOR KO hiPSC-CMs showed a significant reduction in systolic Ca 2+ (p<0.001) compared to controls. RNA-seq data, validated by KEGG, Reactome and WIKI Pathway analyses (control N=2, GSNOR KO N=3), revealed upregulation of mitochondrial complex I and IV enzymes in female GSNOR KO hiPSC-CMs (P<0.01), suggesting increased expression of genes related to oxidative phosphorylation. Conclusions: GSNOR deficiency reduced systolic calcium and increased the expression of oxidative phosphorylation genes, which may contribute to the impaired ability of the GSNOR KO female cardiomyocytes to respond to stress.
No takes yet. Share an insight, caveat, or question.
Asensi et al. (2025) studied GSNOR deficiency / Myocardial infarction. GSNOR deficiency (GSNOR KO) vs. Wild-type / parental control hiPSC-CMs was evaluated on Systolic calcium levels and oxidative phosphorylation-related gene expression (p=<0.001). GSNOR deficiency in female hiPSC-derived cardiomyocytes significantly reduced systolic calcium (p<0.001) and upregulated mitochondrial complex I and IV enzymes (P<0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: